Susquehanna International Group, LLP Avadel Pharmaceuticals PLC Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$9.64 - $14.59 $1.19 Million - $1.8 Million	123,425 New	123,425 $1.74 Million
Q2 2023 Aug 11, 2023	SELL	$8.48 - $16.48 $1.7 Million - $3.29 Million	-199,903 Reduced 60.51%	130,473 $2.15 Million
Q1 2023 May 16, 2023	BUY	$6.41 - $9.95 $1.09 Million - $1.69 Million	169,466 Added 105.32%	330,376 $3.03 Million
Q4 2022 Feb 14, 2023	SELL	$5.02 - $10.0 $301,998 - $601,590	-60,159 Reduced 27.21%	160,910 $1.15 Million
Q3 2022 Nov 14, 2022	BUY	$2.57 - $7.31 $568,147 - $1.62 Million	221,069 New	221,069 $1.11 Million
Q1 2022 May 16, 2022	BUY	$5.46 - $8.29 $228,298 - $346,629	41,813 Added 19.12%	260,471 $1.78 Million
Q4 2021 Feb 14, 2022	SELL	$7.34 - $11.18 $1.26 Million - $1.91 Million	-171,056 Reduced 43.89%	218,658 $1.77 Million
Q3 2021 Nov 15, 2021	BUY	$6.49 - $9.91 $1.31 Million - $2 Million	201,502 Added 107.06%	389,714 $3.82 Million
Q2 2021 Aug 11, 2021	BUY	$6.73 - $9.05 $493,551 - $663,690	73,336 Added 63.84%	188,212 $1.27 Million
Q1 2021 May 17, 2021	SELL	$6.61 - $10.07 $488,710 - $744,525	-73,935 Reduced 39.16%	114,876 $1.04 Million
Q4 2020 Feb 16, 2021	SELL	$5.03 - $7.95 $161,090 - $254,606	-32,026 Reduced 14.5%	188,811 $1.26 Million
Q3 2020 Nov 16, 2020	SELL	$5.02 - $8.98 $366,846 - $656,231	-73,077 Reduced 24.86%	220,837 $1.11 Million
Q4 2019 Feb 14, 2020	BUY	$3.34 - $7.7 $337,924 - $779,047	101,175 Added 52.49%	293,914 $2.22 Million
Q3 2019 Nov 14, 2019	BUY	$1.92 - $4.47 $181,152 - $421,744	94,350 Added 95.89%	192,739 $802,000
Q2 2019 Aug 16, 2019	BUY	$1.09 - $3.19 $981 - $2,871	900 Added 0.92%	98,389 $284,000
Q2 2019 Aug 14, 2019	BUY	$1.09 - $3.19 $76,766 - $224,665	70,428 Added 260.26%	97,489 $282,000
Q1 2019 May 15, 2019	SELL	$1.44 - $3.29 $9,102 - $20,796	-6,321 Reduced 18.94%	27,061 $39,000
Q4 2018 Feb 14, 2019	SELL	$1.74 - $4.66 $5,232 - $14,012	-3,007 Reduced 8.26%	33,382 $86,000
Q3 2018 Nov 14, 2018	SELL	$4.08 - $7.14 $61,306 - $107,285	-15,026 Reduced 29.22%	36,389 $160,000
Q2 2018 Aug 14, 2018	SELL	$5.89 - $7.78 $1,519 - $2,007	-258 Reduced 0.5%	51,415 $315,000
Q1 2018 May 15, 2018	BUY	$6.76 - $11.7 $115,548 - $199,988	17,093 Added 49.43%	51,673 $377,000
Q4 2017 Feb 14, 2018	BUY	$8.03 - $11.25 $188,367 - $263,902	23,458 Added 210.92%	34,580 $284,000
Q3 2017 Nov 14, 2017	BUY	$8.35 - $10.5 $92,868 - $116,781	11,122	11,122 $117,000

Others Institutions Holding AVDL

# of Institutions

Shares Held

1.07M

Call Options Held

Put Options Held

View Full List

About AVADEL PHARMACEUTICALS PLC

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $661M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

More about AVDL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account